Last week, www.selectscience.net reported
on 31 news stories the day they happened,
so if you need to keep up to speed on
the latest business developments in
chemistry and life science, make the news
ticker on www.selectscience.net part of
your daily routine.
Andrew Smith (andrew at selectscience.net)
Editor, www.selectscience.net
Last week's headlines were:
Peptide Therapeutics Appoints New Chairman
Cantab Pharmaceuticals Reports First Quarter Financial Results and
Significant Progress in Key Development Programs
CuraGen Announces Completion of High Resolution Rat Genome Maps
QIAGEN Announces 2-For-1 Stock Split and Conversion of Currency of its Par
Value to EURO
CLONTECH Receives ISO 9000 Certification
Molecular Devices announces the Acquisition of Skatron Instruments AS
Lonza Biologics and Genzyme Transgenics Corporation to Establish Strategic
Alliance for Biopharmaceutical Production
Millipore Acquires Bioprocessing Corp.
QIAGEN Joins Valentis-DS Biologics Alliance for Manufacturing and Sales of
Plasmid DNA
Genmab Obtains Rights to IL15 Antibody Patents
Roche Diagnostics Takes License Under Organon Teknika's Nucleic Acid
Extraction Technology
Vysis Reports Positive Q1 1999 Results
Hemagen Announces 34% Increase in Sales From Same Quarter Last Year
Protein Design Labs Announces Presentations of Clinical Results Using SMART
Anti-CD3 Antibody
Biogen Names Jennifer Jackson, Ph.D., as Director, Regulatory Affairs
Life Technologies Completes Acquisition of Process Chromatography and
Research Products Businesses from BioSepra
IntegrLifeSciences Reports Results From 1999 Annual Meeting of Stockholders
Steris Corporation to Acquire Assets of Ricerca, Inc.
Biogen Names Michael Gilman, Ph.D., as Research Director of Molecular
Biology
ThermoQuest Announces First Quarter Results
Thermo BioAnalysis Announces First Quarter Results
Thermo Instrument Systems Announces First Quarter Results
Thermo Optek Announces First Quarter Results
Perkin-Elmer Sells Its Environmental And Process Analysis Division To SICK
AG
PE Corporation Declares Dividend
Cerep SA Announces Drug Discovery Partnership with Pfizer
New Scientific Advisory Board at Xenova
Ontogen and Oxford Asymmetry International (OAI) Announce Collaboration
Centocor Announces Senior Executive Appointment and Promotions
Sale of Nycomed Pharma Completed
Trinity Biotech Responds to Centocor Lawsuit
